Department of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Lab Invest. 2010 Oct;90(10):1468-81. doi: 10.1038/labinvest.2010.130. Epub 2010 Jul 19.
The pathological process of glomerulonephritis (GN) includes glomerular capillary damage, and vascular endothelial growth factor (VEGF) has an important role in glomerular capillary repair in GN. We examined the effect of inhibition of glomerular capillary repair after capillary injury in GN. Experimental Thy-1 GN was induced in rats that were divided into two groups: rats that received anti-VEGF neutralizing antibody (50 μg per 100 g body weight per day) and those treated with the vehicle from day 2 to day 9. We assessed the renal function and histopathology serially until week 6. Rats of the Thy-1 GN group showed diffuse glomerular mesangiolysis with ballooning destruction of the capillary network by day 3. VEGF(164) protein levels increased in the damaged glomeruli during days 5 to 10, and endothelial-cell proliferation increased with capillary repair in the vehicle-injected group. Proliferative GN resolved subsequently with decreased mesangial hypercellularity, and recovery of most of the glomeruli to the normal structure was evident by week 6. In contrast, administration of anti-VEGF antibody significantly decreased endothelial-cell proliferation and capillary repair in glomeruli by week 2. Thereafter, glomerular mesangial-cell proliferation and activation continued with persistent infiltration of macrophages. At week 6, segmental glomerular sclerosis developed with mesangial matrix accumulation and proteinuria. Deposition of type I collagen was also noted in sclerotic lesions. We conclude that impaired capillary repair was the underlying mechanism in the prolongation of glomerular inflammation in proliferative GN and in the development of glomerular sclerosis. Capillary repair has an important role in the recovery of glomerular damage and in the resolution of proliferative GN.
肾小球肾炎(GN)的病理过程包括肾小球毛细血管损伤,血管内皮生长因子(VEGF)在 GN 中肾小球毛细血管修复中起重要作用。我们研究了抑制 GN 毛细血管损伤后毛细血管修复对肾小球的影响。采用大鼠 Thy-1 肾炎模型,将大鼠分为两组:一组在第 2 天至第 9 天每天给予抗 VEGF 中和抗体(50μg/100g 体重),另一组给予载体。我们在第 6 周末之前连续评估肾功能和组织病理学。在第 3 天,Thy-1 GN 组大鼠出现弥漫性肾小球系膜溶解,毛细血管网络呈气球样破坏。在第 5 天至第 10 天,受损肾小球中 VEGF(164)蛋白水平增加,内皮细胞增殖增加,伴有血管修复。在载体注射组,增生性 GN 随后消退,系膜细胞增生减少,大多数肾小球结构恢复正常。相比之下,抗 VEGF 抗体治疗显著降低了第 2 周末肾小球内皮细胞增殖和血管修复。此后,肾小球系膜细胞增殖和活化持续存在,巨噬细胞持续浸润。在第 6 周末,节段性肾小球硬化发展,系膜基质积聚和蛋白尿。在硬化病变中也观察到 I 型胶原沉积。我们的结论是,毛细血管修复受损是增生性 GN 中肾小球炎症持续和肾小球硬化发展的潜在机制。毛细血管修复对肾小球损伤的恢复和增生性 GN 的消退具有重要作用。